Reported Earnings • May 31
Full year 2026 earnings released: EPS: ₹3.48 (vs ₹2.49 in FY 2025) Full year 2026 results: EPS: ₹3.48 (up from ₹2.49 in FY 2025). Revenue: ₹1.48b (up 24% from FY 2025). Net income: ₹70.6m (up 40% from FY 2025). Profit margin: 4.8% (up from 4.2% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. New Risk • May 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.2% per year over the past 5 years. Market cap is less than US$10m (₹703.3m market cap, or US$7.35m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.4% average weekly change). Valuation Update With 7 Day Price Move • May 26
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹34.69, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 3.5% over the past three years. Board Change • Apr 01
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Additional Director Maya Vishwakarma was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Mar 30
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₹24.14, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 26% over the past three years. Reported Earnings • Feb 17
Third quarter 2026 earnings released: EPS: ₹0.45 (vs ₹1.22 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.45 (down from ₹1.22 in 3Q 2025). Revenue: ₹358.9m (up 57% from 3Q 2025). Net income: ₹9.18m (down 63% from 3Q 2025). Profit margin: 2.6% (down from 11% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Announcement • Feb 09
Agro Phos (India) Limited to Report Q3, 2026 Results on Feb 14, 2026 Agro Phos (India) Limited announced that they will report Q3, 2026 results at 9:08 AM, Indian Standard Time on Feb 14, 2026 Upcoming Dividend • Sep 16
Upcoming dividend of ₹1.00 per share Eligible shareholders must have bought the stock before 23 September 2025. Payment date: 30 October 2025. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 2.5%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%). New Risk • Sep 13
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Earnings have declined by 20% per year over the past 5 years. Market cap is less than US$10m (₹822.9m market cap, or US$9.32m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.1% average weekly change). Announcement • Sep 09
Agro Phos (India) Limited announces Annual dividend, payable on October 30, 2025 Agro Phos (India) Limited announced Annual dividend of INR 1.0000 per share payable on October 30, 2025, ex-date on September 23, 2025 and record date on September 23, 2025. Announcement • Sep 08
Agro Phos (India) Limited, Annual General Meeting, Sep 30, 2025 Agro Phos (India) Limited, Annual General Meeting, Sep 30, 2025, at 12:30 Indian Standard Time. Location: 93-b, wb scheme no. 94, near bombay hospital, vijay, nagar, indore (mp) 452006., indore India Board Change • Sep 08
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Mahesh Agarwal was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 19
First quarter 2026 earnings released: EPS: ₹2.15 (vs ₹0.10 loss in 1Q 2025) First quarter 2026 results: EPS: ₹2.15 (up from ₹0.10 loss in 1Q 2025). Revenue: ₹399.0m (up 67% from 1Q 2025). Net income: ₹43.7m (up ₹45.7m from 1Q 2025). Profit margin: 11% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Aug 12
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to ₹35.34, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 2.5% over the past three years. New Risk • Aug 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (8.1% average weekly change). Earnings have declined by 31% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹898.3m market cap, or US$10.2m). Valuation Update With 7 Day Price Move • Jul 29
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹42.02, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 21% over the past three years. New Risk • Jun 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 37% per year over the past 5 years. Market cap is less than US$10m (₹745.5m market cap, or US$8.68m). Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change). Buy Or Sell Opportunity • Jun 04
Now 20% undervalued Over the last 90 days, the stock has risen 22% to ₹36.77. The fair value is estimated to be ₹46.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.7% over the last 3 years. Meanwhile, the company has become profitable. New Risk • Mar 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 37% per year over the past 5 years. Market cap is less than US$10m (₹579.4m market cap, or US$6.65m). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change). Valuation Update With 7 Day Price Move • Mar 03
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹27.50, the stock trades at a trailing P/E ratio of 67.7x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 42% over the past three years. Buy Or Sell Opportunity • Feb 13
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 14% to ₹35.34. The fair value is estimated to be ₹44.19, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.7% over the last 3 years. Meanwhile, the company has become profitable. New Risk • Feb 07
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Earnings have declined by 37% per year over the past 5 years. Market cap is less than US$10m (₹755.2m market cap, or US$8.63m). New Risk • Nov 24
New minor risk - Financial position The company has a high level of debt. Net debt to equity ratio: 41% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Market cap is less than US$10m (₹814.2m market cap, or US$9.64m). Minor Risk High level of debt (41% net debt to equity). Reported Earnings • Nov 16
Second quarter 2025 earnings released: EPS: ₹0.21 (vs ₹2.17 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.21 (down from ₹2.17 in 2Q 2024). Revenue: ₹376.1m (down 3.9% from 2Q 2024). Net income: ₹4.35m (down 90% from 2Q 2024). Profit margin: 1.2% (down from 11% in 2Q 2024). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 120 percentage points per year, which is a significant difference in performance. New Risk • Nov 13
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹837.1m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (₹837.1m market cap, or US$9.92m). Announcement • Sep 09
Agro Phos (India) Limited, Annual General Meeting, Sep 27, 2024 Agro Phos (India) Limited, Annual General Meeting, Sep 27, 2024, at 12:30 Indian Standard Time. Location: 93-b, wb scheme no. 94, near bombay hospital, vijay, nagar, indore (mp) 452006., indore India Reported Earnings • Aug 18
First quarter 2025 earnings released: ₹0.10 loss per share (vs ₹0.57 loss in 1Q 2024) First quarter 2025 results: ₹0.10 loss per share (improved from ₹0.57 loss in 1Q 2024). Revenue: ₹272.2m (down 40% from 1Q 2024). Net loss: ₹2.05m (loss narrowed 82% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 104 percentage points per year, which is a significant difference in performance. Board Change • Jul 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Independent Director Tushar Dave was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jun 04
Full year 2024 earnings released: ₹2.59 loss per share (vs ₹2.47 profit in FY 2023) Full year 2024 results: ₹2.59 loss per share (down from ₹2.47 profit in FY 2023). Revenue: ₹1.08b (down 18% from FY 2023). Net loss: ₹52.8m (down 206% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 41% per year, which means it is well ahead of earnings. Reported Earnings • Feb 16
Third quarter 2024 earnings released: ₹2.88 loss per share (vs ₹0.74 profit in 3Q 2023) Third quarter 2024 results: ₹2.88 loss per share (down from ₹0.74 profit in 3Q 2023). Revenue: ₹183.4m (down 46% from 3Q 2023). Net loss: ₹58.5m (down 492% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 54% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹55.80, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 309% over the past three years. New Risk • Jan 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Profit margins are more than 30% lower than last year (3.1% net profit margin). Profit margins are more than 30% lower than last year (3.1% net profit margin). Market cap is less than US$100m (₹968.1m market cap, or US$11.6m). Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹45.20, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 178% over the past three years. New Risk • Nov 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Market cap is less than US$10m (₹732.9m market cap, or US$8.81m). Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Profit margins are more than 30% lower than last year (1.0% net profit margin). Announcement • Sep 07
Agro Phos (India) Limited (NSEI:AGROPHOS) agreed to acquire Shri Tulsi Phosphate Limited for INR 35 million. Agro Phos (India) Limited (NSEI:AGROPHOS) agreed to acquire Shri Tulsi Phosphate Limited for INR 35 million on September 5, 2023. Board of directors of Agro Phos (India) Limited have approved the transaction. New Risk • Aug 04
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.0% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Market cap is less than US$10m (₹691.3m market cap, or US$8.34m). Minor Risk Profit margins are more than 30% lower than last year (1.0% net profit margin). Reported Earnings • Aug 04
First quarter 2024 earnings released: ₹0.57 loss per share (vs ₹1.19 profit in 1Q 2023) First quarter 2024 results: ₹0.57 loss per share (down from ₹1.19 profit in 1Q 2023). Revenue: ₹451.6m (up 50% from 1Q 2023). Net loss: ₹11.5m (down 148% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Jun 03
Full year 2023 earnings released: EPS: ₹2.47 (vs ₹2.88 in FY 2022) Full year 2023 results: EPS: ₹2.47 (down from ₹2.88 in FY 2022). Revenue: ₹1.31b (up 13% from FY 2022). Net income: ₹50.0m (down 14% from FY 2022). Profit margin: 3.8% (down from 5.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Apr 12
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹41.60, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 547% over the past three years. Reported Earnings • Feb 15
Third quarter 2023 earnings released: EPS: ₹0.74 (vs ₹1.57 in 3Q 2022) Third quarter 2023 results: EPS: ₹0.74 (down from ₹1.57 in 3Q 2022). Revenue: ₹342.7m (down 11% from 3Q 2022). Net income: ₹14.9m (down 53% from 3Q 2022). Profit margin: 4.4% (down from 8.3% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improved over the past week After last week's 28% share price gain to ₹49.50, the stock trades at a trailing P/E ratio of 13.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 67% over the past three years. Reported Earnings • Nov 16
Second quarter 2023 earnings released: EPS: ₹0.66 (vs ₹0.40 in 2Q 2022) Second quarter 2023 results: EPS: ₹0.66 (up from ₹0.40 in 2Q 2022). Revenue: ₹407.8m (up 18% from 2Q 2022). Net income: ₹13.4m (up 66% from 2Q 2022). Profit margin: 3.3% (up from 2.3% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. Announcement • Sep 10
Agro Phos (India) Limited, Annual General Meeting, Sep 30, 2022 Agro Phos (India) Limited, Annual General Meeting, Sep 30, 2022, at 12:30 Indian Standard Time. Location: Hotel Surya 5/5, surya Circle Nanth mandir Road South Tukoganj Indore India Valuation Update With 7 Day Price Move • Sep 02
Investor sentiment improved over the past week After last week's 26% share price gain to ₹43.85, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 50% over the past three years. Reported Earnings • Aug 12
First quarter 2023 earnings released: EPS: ₹1.19 (vs ₹0.63 in 1Q 2022) First quarter 2023 results: EPS: ₹1.19 (up from ₹0.63 in 1Q 2022). Revenue: ₹302.0m (up 42% from 1Q 2022). Net income: ₹24.1m (up 88% from 1Q 2022). Profit margin: 8.0% (up from 6.0% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Aug 02
Investor sentiment improved over the past week After last week's 16% share price gain to ₹34.70, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 61% over the past three years. Valuation Update With 7 Day Price Move • Jun 20
Investor sentiment improved over the past week After last week's 16% share price gain to ₹36.50, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 16x in the Chemicals industry in India. Total loss to shareholders of 55% over the past three years. Reported Earnings • Jun 04
Full year 2022 earnings released: EPS: ₹2.88 (vs ₹1.57 in FY 2021) Full year 2022 results: EPS: ₹2.88 (up from ₹1.57 in FY 2021). Revenue: ₹1.17b (up 96% from FY 2021). Net income: ₹58.3m (up 83% from FY 2021). Profit margin: 5.0% (down from 5.3% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • May 18
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₹45.85, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total loss to shareholders of 37% over the past three years. Valuation Update With 7 Day Price Move • Apr 29
Investor sentiment improved over the past week After last week's 89% share price gain to ₹62.70, the stock trades at a trailing P/E ratio of 25.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 11% over the past three years. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improved over the past week After last week's 32% share price gain to ₹30.40, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 56% over the past three years. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment improved over the past week After last week's 21% share price gain to ₹25.45, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 18x in the Chemicals industry in India. Total loss to shareholders of 61% over the past three years. Reported Earnings • Feb 17
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹1.57 (up from ₹0.88 in 3Q 2021). Revenue: ₹383.1m (up 132% from 3Q 2021). Net income: ₹31.9m (up 78% from 3Q 2021). Profit margin: 8.3% (down from 11% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment improved over the past week After last week's 21% share price gain to ₹20.50, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total loss to shareholders of 57% over the past three years. Valuation Update With 7 Day Price Move • Oct 07
Investor sentiment improved over the past week After last week's 19% share price gain to ₹18.45, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 47% over the past three years. Reported Earnings • Aug 18
First quarter 2022 earnings released: EPS ₹0.63 (vs ₹0.21 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹212.9m (up 44% from 1Q 2021). Net income: ₹12.8m (up 191% from 1Q 2021). Profit margin: 6.0% (up from 3.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Aug 12
Investor sentiment improved over the past week After last week's 19% share price gain to ₹17.90, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 51% over the past three years. Valuation Update With 7 Day Price Move • Jul 07
Investor sentiment improved over the past week After last week's 22% share price gain to ₹16.35, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 53% over the past three years. Reported Earnings • Jul 06
Full year 2021 earnings released: EPS ₹1.57 (vs ₹1.93 in FY 2020) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: ₹602.1m (up 16% from FY 2020). Net income: ₹31.8m (down 19% from FY 2020). Profit margin: 5.3% (down from 7.5% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • May 17
Investor sentiment improved over the past week After last week's 21% share price gain to ₹14.10, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 64% over the past three years. Valuation Update With 7 Day Price Move • Mar 24
Investor sentiment improved over the past week After last week's 27% share price gain to ₹14.25, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 16x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years. Is New 90 Day High Low • Mar 15
New 90-day low: ₹12.15 The company is down 36% from a price of ₹19.05 on 15 December 2020. Underperformed the Indian market, which is up 14% over the last 90 days. Lagged the Chemicals industry, which is up 9.0% over the same period. Reported Earnings • Feb 17
Third quarter 2021 earnings released: EPS ₹0.88 (vs ₹1.35 in 3Q 2020) The company reported a poor third quarter result with weaker earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: ₹94.1m (down 36% from 3Q 2020). Net income: ₹17.9m (down 35% from 3Q 2020). Profit margin: 19% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings. Executive Departure • Feb 17
Independent Director has left the company On the 13th of February, Omprakash Chourey's tenure as Independent Director ended after 2.6 years in the role. We don't have any record of a personal shareholding under Omprakash's name. A total of 3 executives have left over the last 12 months. Announcement • Feb 14
Agro Phos (India) Limited Announces Resignation of Omprakash Chourey as Independent Director Agro Phos (India) Limited announced that Mr. Omprakash Chourey has tendered his resignation from of Independent Director of the company with effect from closing of business hours of 13 February 2021. Announcement • Jan 07
Agro Phos (India) Limited Announces Demise of Ashok Pande, Non-Executive Independent Director Agro Phos (India) Limited announced the demise of Ashok Pande (DlN: 0837a6a6), non-executive independent director of the company, on 04 January,2021. Valuation Update With 7 Day Price Move • Dec 23
Investor sentiment deteriorated over the past week After last week's 23% share price decline to ₹15.50, the stock is trading at a trailing P/E ratio of 7.5x, down from the previous P/E ratio of 9.7x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 52%. Valuation Update With 7 Day Price Move • Nov 25
Market bids up stock over the past week After last week's 18% share price gain to ₹9.90, the stock is trading at a trailing P/E ratio of 4.9x, up from the previous P/E ratio of 4.2x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 66%. Is New 90 Day High Low • Nov 17
New 90-day low: ₹7.85 The company is down 28% from its price of ₹10.85 on 19 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. Is New 90 Day High Low • Oct 27
New 90-day low: ₹8.65 The company is down 10.0% from its price of ₹9.60 on 29 July 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Oct 08
New 90-day low: ₹8.95 The company is down 32% from its price of ₹13.25 on 10 July 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. Announcement • Sep 14
Agro Phos (India) Limited to Report Q1, 2021 Results on Sep 15, 2020 Agro Phos (India) Limited announced that they will report Q1, 2021 results on Sep 15, 2020 Announcement • Jul 17
Agro Phos (India) Limited to Report Q4, 2019 Results on Feb 12, 2020 Agro Phos (India) Limited announced that they will report Q4, 2019 results on Feb 12, 2020